Patent Yard Sign in
Expired Canadian patentCanada

Immediate release ph-independent solid dosage form of cisapride

CA 2201264 C · Owner: Smans, Guido Franciscus · Inventors: Gilis, Paul Marie Victor; Smans, Guido Franciscus; Gijs, Guido Jozef Maria

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention concerns oral dosage forms of some particular salts of cisapride more particularly cisapride-(L)-tartrate cisapride-(D)-tartrate, cisapride-sulfate or, cisapride citrate, which avoid drugfood interaction and which allow comedication of agents that increase the pH of the stomach. The invention particularly relates to solid oral dosage forms suitable for rapid dissolution. The present invention also concerns tablets which can be prepared via direct compression.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 27, 1997 and granted August 10, 1999. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 27, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 27, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 27, 1997
GrantedAugust 10, 1999
Term endedMarch 27, 2017
Patent numberCA 2201264 C
Classification (IPC)A61K31/44 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedMarch 27, 1997Patent grantedAug 10, 1999Term endedMarch 27, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.